SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 4, 2026

IRMD

IRADIMED CORP
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $203K total
Actionable Insight • Neutral

The sales are too small in dollar value and as a fraction of market cap to convey a negative signal. CEO Susi's 400-share sale is particularly minor. No follow-up action warranted; treat as routine portfolio rebalancing. Monitor next Form 4 filings for any step-change in selling cadence or magnitude.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IRMD ▼ -7.19% at T+60d
NEUTRAL call -7.19% · α vs SPY -11.19% · entry $93.07 → $86.38
Entry = T+0 close
Jun 4, 2026
via day close
T+1d
+1.42%
call +1.42% · α +1.19%
$94.39
settled 5mo ago
T+5d
+0.57%
call +0.57% · α 0.00%
$93.60
settled 5mo ago
T+20d
+9.92%
call +9.92% · α +8.06%
$102.30
settled 4mo ago
T+60d
-7.19%
call -7.19% · α -11.19%
$86.38
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Two IRMD insiders—CEO Roger Susi and Director Hilda Scharen-Guivel—made open-market sales totaling ~$203K over a four-day window. At $1.2B market cap, the aggregate sales represent ~0.02% of market cap, which is statistically trivial. The CEO sold just 400 shares ($35K), consistent with routine diversification at this executive's level, and the Director's $168K sale is also immaterial. No C-suite cluster selling signal here.

Key Financial Metrics

Direction
selling
Total Value
$203.2K
Insiders
2

Key Facts

  • CEO Roger Susi sold 400 shares at $88.68 for $35K on June 1, 2026
  • Director Hilda Scharen-Guivel sold 1,766 shares at $95.00 for $168K on June 4, 2026
  • Total cluster value of $203K equals ~0.02% of IRMD's $1.2B market cap
  • Both transactions are open-market sales (code 'S')
  • No C-suite cluster buying — both sales, no purchases

Financial Impact

Total insider sales of ~$203K vs. market cap of $1.2B — approximately 0.02% of market cap

insider holdings

Risk Factors

  • Minimal risk — no material insider selling signal
  • The CEO and a Director both selling within the same week is optically notable but economically insignificant

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IRMD-1780604558520
7 reports for IRMD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IRMD — sortable, filterable
TypeNow
Jul 31, 2026
12w ago
8-K
MIXED ★ 5/10
$90.86 $84.63▼ −6.86%▼ −9.31%$84.32 (−7.19%)
Jul 31, 2026
12w ago
Press Release
MIXED ★ 5/10
$90.86 $84.63▼ −6.86%▼ −9.31%$84.32 (−7.19%)
Jul 24, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$95.08 $87.65▼ −7.81%▼ −11.52%$84.32 (−11.31%)
Jun 4, 2026
20w ago
Insider Cluster
NEUTRAL ★ 3/10
$93.07 $86.38▼ −7.19%▼ −11.19%$84.32 (−9.40%)
May 20, 2026
22w ago
Press Release
NEUTRAL ★ 3/10
$90.40 $86.95▼ −3.82%▼ −8.82%$84.32 (−6.72%)
May 1, 2026
25w ago
Press Release
BULLISH ★ 7/10
$87.15 $94.83▲ +8.81%▲ +5.74%$84.32 (−3.24%)
Apr 27, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$89.08 $94.08▲ +5.61%▲ +0.84%$84.32 (−5.34%)
Showing 7 of 7

US Market Status

Market Open — Closes in 1h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 4, 2026